Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Malignancy

Clinical trial condition

Hematologic Malignancy

Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

166 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Malignancy trial results

Completed

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

NCT02711852

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations: Denver, Colorado, United States

Sarasota, Florida, United States

Nashville, Tennessee, United States

UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients

NCT04852796

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +17 more
Locations: Centre Hospitalier de Quimper Cornouaille Quimper, France

View Trial Details

Completed

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

NCT03903185

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +22 more
Locations: Faculty of Medicine Ain Shams Research Institute- Clinical Research Center (MASRI-CRC) Cairo, Cairo Governorate, Egypt

Pediatric Hematology Oncology and BMT Department, Faculty of Medicine, Ain Shams University Cairo, Egypt

View Trial Details

Completed

Expressive Helping for Stem Cell Transplant Patients

NCT03800758

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations: Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States

Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

NCT03699631

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations: Froedtert Hospital Milwaukee, Wisconsin, United States

View Trial Details

Completed

Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.

NCT05270655

Conditions: Anxiety, Anxiety Disorders, Behavior, +10 more
Locations: Tikur Anbesa specialised hospital Addis Ababa, Ethiopia

University of Gondar specialised hospital Gonder, Ethiopia

View Trial Details

Completed

Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic Failure

NCT03399149

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +6 more
Locations: Hematologic unit - Hospital Grenoble Alpes Grenoble, France

Intensive Care Unit - Hospital Grenoble-Alpes Grenoble, France

View Trial Details

Completed

Patient-Centered Care for the Older Adult With Hematologic Malignancy

NCT02359838

Conditions: Frailty, Hematologic Diseases, Hematologic Malignancy, +6 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Effects of NMES and Exercise in Hematological Cancer

NCT04755465

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +12 more
Locations: Acibadem University Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

NCT04710212

Conditions: Agranulocytosis, Bloodstream Infection, Cytopenia, +18 more
Locations: University of California San Fransisco Medical Center San Francisco, California, United States

Hackensack Meridian Health Nutley, New Jersey, United States

Mount Sinai Hospital New York, United States

University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details